Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

New therapies for rare skin diseases show promise but need more research.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Combination therapies might work better for some vitiligo patients, but results vary.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Inclisiran is effective at lowering cholesterol.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Human insulin via microinfusion may effectively improve atrophic acne scars.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Imipramine and pseudoephedrine treatment can effectively restore normal ejaculation in patients with diabetes, increasing their chances for pregnancy.

Some alternative treatments for vitiligo show promise but need more research to confirm their safety and effectiveness.

Improved CRBN ligands make protein degraders more effective and drug-like.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Upadacitinib effectively treats psoriasis and lichen planus together.

Upadacitinib effectively treats pyoderma gangrenosum.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.